- Home
- UOKA vs TTNP Comparison
UOKA vs TTNP Comparison
Compare UOKA & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UOKA
- TTNP
- Stock Information
- Founded
- UOKA 2002
- TTNP 1991
- Country
- UOKA United Kingdom
- TTNP United States
- Employees
- UOKA 11
- TTNP N/A
- Industry
- UOKA
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UOKA
- TTNP Health Care
- Exchange
- UOKA NYSE
- TTNP Nasdaq
- Market Cap
- UOKA 2.9M
- TTNP 3.0M
- IPO Year
- UOKA N/A
- TTNP 1996
- Fundamental
- Price
- UOKA $0.19
- TTNP $3.28
- Analyst Decision
- UOKA
- TTNP
- Analyst Count
- UOKA 0
- TTNP 0
- Target Price
- UOKA N/A
- TTNP N/A
- AVG Volume (30 Days)
- UOKA 19.5M
- TTNP 36.8K
- Earning Date
- UOKA 02-16-2025
- TTNP 03-31-2025
- Dividend Yield
- UOKA N/A
- TTNP N/A
- EPS Growth
- UOKA N/A
- TTNP N/A
- EPS
- UOKA N/A
- TTNP N/A
- Revenue
- UOKA $114,849.00
- TTNP N/A
- Revenue This Year
- UOKA N/A
- TTNP N/A
- Revenue Next Year
- UOKA N/A
- TTNP N/A
- P/E Ratio
- UOKA N/A
- TTNP N/A
- Revenue Growth
- UOKA 289.97
- TTNP N/A
- 52 Week Low
- UOKA $0.13
- TTNP $3.03
- 52 Week High
- UOKA $1.90
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- UOKA N/A
- TTNP 46.75
- Support Level
- UOKA N/A
- TTNP $3.17
- Resistance Level
- UOKA N/A
- TTNP $3.50
- Average True Range (ATR)
- UOKA 0.00
- TTNP 0.32
- MACD
- UOKA 0.00
- TTNP -0.01
- Stochastic Oscillator
- UOKA 0.00
- TTNP 19.32
About UOKA MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.